nach oben

Erschienen in:

01.09.2013 | Short Communication

Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything?

verfasst von: Mark Clendenning, Michael D. Walsh, Judith Balmana Gelpi, Stephen N. Thibodeau, Noralane Lindor, John D. Potter, Polly Newcomb, Loic LeMarchand, Robert Haile, Steve Gallinger, John L. Hopper, Mark A. Jenkins, Christophe Rosty, Joanne P. Young, Daniel D. Buchanan, Colorectal Cancer Family Registry

Erschienen in: Familial Cancer | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Current screening practices have been able to identify PMS2 mutations in 78 % of cases of colorectal cancer from the Colorectal Cancer Family Registry (Colon CFR) which showed solitary loss of the PMS2 protein. However the detection of large-scale deletions in the 3′ end of the PMS2 gene has not been possible due to technical difficulties associated with pseudogene sequences. Here, we utilised a recently described MLPA/long-range PCR-based approach to screen the remaining 22 % (n = 16) of CRC-affected probands for mutations in the 3′ end of the PMS2 gene. No deletions encompassing any or all of exons 12 through 15 were identified; therefore, our results suggest that 3′ deletions in PMS2 are not a frequent occurrence in such families.

Nur mit Berechtigung zugänglich

Vaughn CP, Hart KJ, Samowitz WS, Swensen JJ (2011) Avoidance of pseudogene interference in the detection of 3′ deletions in PMS2. Hum Mutat 32:1063–1071

De Vos M, Hayward BE, Picton S, Sheridan E, Bonthron DT (2004) Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. Am J Hum Genet 74:954–964PubMedCrossRef

Nakagawa H et al (2004) Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Cancer Res 64:4721–4727PubMedCrossRef

Senter L et al (2008) The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135:419–428PubMedCrossRef

Vaughn CP et al (2010) Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes. Hum Mutat 31:588–593PubMed

Clendenning M et al (2006) Long-range PCR facilitates the identification of PMS2-specific mutations. Hum Mutat 27:490–495PubMedCrossRef

Schouten JP et al (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57PubMedCrossRef

Pavlicek AR et al (2005) Traffic of genetic information between segmental duplications flanking the typical 22q11.2 deletion in velo-cardio-facial syndrome/DiGeorge syndrome. Genome Res 15:1487–1495PubMedCrossRef

van der Klift HM et al (2010) Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients. Hum Mutat 31:578–587PubMed

10.

Newcomb PA et al (2007) Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 16:2331–2343PubMedCrossRef

11.

Lindor NM et al (2002) Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 20:1043–1048PubMedCrossRef

12.

Vaughn CP et al (2012) The frequency of previously undetectable deletions involving 3′ exons of the PMS2 gene. Genes Chromosom Cancer 52:107–112PubMedCrossRef

13.

Clendenning M et al (2011) Mutation deep within an intron of MSH2 causes Lynch syndrome. Fam Cancer 10:297–301PubMedCrossRef

14.

van der Klift HM et al (2005) Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromosom Cancer 44:123–138PubMedCrossRef

Titel: Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything?
verfasst von: Mark Clendenning
Michael D. Walsh
Judith Balmana Gelpi
Stephen N. Thibodeau
Noralane Lindor
John D. Potter
Polly Newcomb
Loic LeMarchand
Robert Haile
Steve Gallinger
John L. Hopper
Mark A. Jenkins
Christophe Rosty
Joanne P. Young
Daniel D. Buchanan
Colorectal Cancer Family Registry
Publikationsdatum: 01.09.2013
Verlag: Springer Netherlands
Erschienen in: Familial Cancer / Ausgabe 3/2013
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-012-9597-4

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything?

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Splice site mutations in mismatch repair genes and risk of cancer in the general population

Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer

Mutation screening in a Norwegian cohort with pheochromocytoma

Detection of large deletions in the VHL gene using a Real-Time PCR with SYBR Green

Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes

Unmet support needs and distress among women with a BRCA1/2 mutation

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie